Latest Payments News

Firebird Metals has secured a Perth site and placed all major equipment orders for its Australian Demonstration Plant, backed by a A$2 million ARENA grant. Independent testing confirms ultra-high purity manganese sulphate production, reinforcing its technology's potential.

BetMakers Technology Group delivered a robust Q4 FY26 with revenue rising 9.4% to $24.2 million and adjusted EBITDA nearly doubling to $4.5 million, driven by new commercial deals and operational efficiencies.

Sinclair Gold has pushed gold mineralisation deeper at its Mt Henry project, with initial drilling results confirming significant extensions beyond the existing 915,000oz resource. Backed by a $30m placement and a royalty deal, the company is well-funded to continue its 50,000m drilling campaign.

Titan Minerals has ramped up drilling at its Dynasty Gold Project, confirming extensions to mineralisation and advancing scoping studies ahead of a resource upgrade targeted for early 2027.

BLS Pharmaceuticals capped FY2026 with record quarterly revenue and operating cash flow, driven by international expansion and new supply agreements across regulated markets.

Black Rock Mining has secured an extension to its US$204 million credit facility to November 2026, providing crucial runway to finalise equity funding for its Mahenge Graphite Project. Early works are nearing completion, positioning the project for construction pending full funding and Final Investment Decision.

Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.

BCAL Diagnostics has strengthened its leadership, advanced breast cancer detection tests, and secured key funding and strategic investments to underpin its FY2027 growth plans.

Patagonia Lithium (ASX:PL3) reported solid progress in its June quarter, hitting key milestones in drilling, pump testing, and resource modelling at its Argentine lithium brine projects, supported by a strong cash position following recent capital raises.

Resolute Mining reported Q2 2026 gold production of 45,192 ounces with steady operations, while Doropo construction progresses on schedule and the ABC Project's inferred resource grows to 3 million ounces.

Epiminder has leveraged its $125 million IPO to advance clinical enrolments, boost Medicare reimbursement, and develop its next-generation Minder device, positioning for a commercial launch in early 2028.

Xenitra Limited (ASX:XEN) has turned around its cash flow in Q4 FY26, reporting positive operating cash flow of A$0.8 million driven by a leaner cost base and a shift towards higher-margin OTC medicines and blockchain-enabled OPAL tokenised sales.